New Normal is a modern autoflowering cultivar derived from its sole parent, Chikara. This strain is designed for accessibility, maintaining an easy difficulty rating for cultivators working in both indoor and outdoor environments. Despite its straightforward cultivation requirements, the plant produces a low yield and finishes its flowering cycle in 75 days. Its genetic influence is sustained through the notable offspring Serendipity.

The chemical profile of New Normal is defined by a complex arrangement of eleven distinct terpenes, led by a dominant presence of pinene. This primary note is followed by myrcene, caryophyllene, limonene, and ocimene, with additional contributions from beta-pinene, humulene, linalool, bisabolol, guaiol, and nerolidol. This progression of terpenes dictates the plant's aromatic and sensory experience, grounding the high-THC profile in this specific hierarchy of volatile compounds.

Consumers of New Normal report a cannabinoid-driven experience that is primarily characterised by feelings of relaxation, happiness, and an uplifted mood. These effects make the strain a functional choice for those seeking relief from stress and pain, or aid in achieving sleep. As a modern selection in the contemporary market, its legacy is currently cemented by its role in producing the progeny Serendipity.